Table 4.
Risk for benign abdominal neoplasia detected via abdominal cross-sectional imaging.
| Benign abdominal neoplasm | Cases (adrenocortical tumor) | Controls (normal adrenal) | OR (95% CI) | AOR (95% CI)∗ |
|---|---|---|---|---|
| n | 400 | 400 | ||
| Hepatobiliary hemangioma or adenoma | 26 (6.5%) | 19 (4.8%) | 1.39 (0.76, 2.59) | 1.30 (0.61, 2.79) |
| Hepatic cyst | 109 (27.3%) | 91 (22.8%) | 1.27 (0.93, 1.75) | 1.44 (0.98, 2.17) |
| Intraductal pancreatic mucinous neoplasm | 34 (8.5%) | 18 (4.5%) | 1.97 (1.11, 3.62) | 2.22 (1.11, 4.63) |
| Splenic hemangioma and cyst | 16 (4.0%) | 10 (2.5%) | 1.62 (0.74, 3.75) | 4.46 (0.92, 7.01) |
| Renal angiomyolipoma | 9 (2.3%) | 4 (1.0%) | 2.28 (0.73, 8.46) | 4.50 (0.94, 33.10) |
| Renal cyst | 216 (54.0%) | 167 (41.8%) | 1.64 (1.24, 2.16) | 1.25 (0.86, 1.81) |
Note. The unadjusted and adjusted∗ odds ratio for patients with benign adrenocortical tumors (cases) compared with those with normal adrenal glands (controls) are presented along with 95% confidence intervals for each benign abdominal neoplasm. AOR: adjusted odds ratio; ∗adjusted for age, sex, race, smoking status, BMI, duration imaging interval, hypertension, hyperlipidemia, composite diabetes (diabetes or prediabetes), coronary artery disease, and myocardial infarction.